You will move to an external webpage. Are you sure?

Nobelpharma

News & Press Release

  • 2017-12-15 Product Information

Marketing Approval Granted for TITANBRIDGETM First SAKIGAKE Designated Medical Device to Treat Adductor Spasmodic Dysphonia

  1. 前の記事へ
  2. 一覧へ戻る（英語）
  3. 次の記事へ
PAGE TOP
  1. HOME
  2. News & Press Release
  3. Marketing Approval Granted for TITANBRIDGETM First SAKIGAKE Designated Medical Device to Treat Adductor Spasmodic Dysphonia